AI Analysis

How does RAD.AX make money? Does RAD.AX have pricing power? What's the Earnings Whisper? Will RAD.AX profit more as the business scales? What is RAD.AX's management track record? Is RAD.AX's current price justified?

Radiopharm Theranostics Limited

AUD 0.01 -$0.02 (-72.00%)

ASX · 16 Sep 2026 01:51 UTC

Previous Close

AUD 0.01

Day Range

AUD 0.01AUD 0.01

Year Range

AUD 0.01AUD 0.04

Market Cap

16.55M

AVG Volume

5.67M

Trailing/Forward PE

-0.45/-

PEG ratio

0.12

Dividend Yield

Next Earnings Date

2027-02-26

Primary Exchange

Australian Securities Exchange

Free Cash Flow Yield

RAD.AX Free Cash Flow Yield by year
Period	Free Cash Flow Yield
Sep 26	-248.72%
Sep 26	-248.72%
Sep 26	-221.08%
Aug 26	-221.08%
Aug 26	-198.97%
Aug 26	-180.89%
Aug 26	-165.81%
Jul 26	-142.12%
Jul 26	-104.72%
Jul 26	-99.49%
Jul 26	-104.72%
Jul 26	-99.49%
Jun 26	-104.72%
Jun 26	-99.49%
Jun 26	-99.49%
Jun 26	-99.49%
May 26	-99.49%
May 26	-94.75%
May 26	-94.75%
May 26	-104.72%
May 26	-104.72%
Apr 26	-99.49%
Apr 26	-99.49%
Apr 26	-90.44%
Apr 26	-94.75%
Mar 26	-127.67%
Mar 26	-127.67%
Mar 26	-116.06%
Mar 26	-121.59%
Feb 26	-111.02%
Feb 26	-116.06%
Feb 26	-116.06%
Feb 26	-121.59%
Jan 26	-121.59%
Jan 26	-111.02%
Jan 26	-102.14%
Jan 26	-102.14%
Jan 26	-102.14%
Dec 25	-94.57%
Dec 25	-98.21%
Dec 25	-134.39%
Dec 25	-116.06%
Nov 25	-116.06%
Nov 25	-121.59%
Nov 25	-116.06%
Nov 25	-111.02%
Oct 25	-106.39%
Oct 25	-98.21%
Oct 25	-69.01%
Oct 25	-69.01%
Oct 25	-77.38%
Sep 25	-515.87%
Sep 25	-482.58%
Sep 25	-482.58%
Sep 25	-534.29%
Aug 25	-534.29%
Aug 25	-554.08%
Aug 25	-575.39%
Aug 25	-623.34%
Aug 25	-650.44%
Jul 25	-650.44%
Jul 25	-680.01%
Jul 25	-680.01%
Jul 25	-650.44%
Jun 25	-680.01%
Jun 25	-623.34%
Jun 25	-575.39%
Jun 25	-598.4%
May 25	-623.34%
May 25	-712.39%
May 25	-680.01%
May 25	-712.39%
May 25	-650.44%
Apr 25	-712.39%
Apr 25	-680.01%
Apr 25	-650.44%
Apr 25	-650.44%
Mar 25	-484.27%
Mar 25	-466.98%
Mar 25	-466.98%
Mar 25	-435.85%
Feb 25	-502.9%
Feb 25	-544.81%
Feb 25	-523.01%
Feb 25	-523.01%
Jan 25	-523.01%
Jan 25	-484.27%
Jan 25	-466.98%
Jan 25	-373.58%
Jan 25	-523.01%
Dec 24	-568.49%
Dec 24	-544.81%
Dec 24	-450.87%
Dec 24	-421.79%
Nov 24	-466.98%
Nov 24	-523.01%
Nov 24	-523.01%
Nov 24	-544.81%
Nov 24	-544.81%
Oct 24	-502.9%

Price to Sales

RAD.AX Price to Sales by year
Period	Price to Sales
Sep 26	1.88
Sep 26	1.88
Sep 26	2.11
Aug 26	2.11
Aug 26	2.35
Aug 26	2.58
Aug 26	2.82
Jul 26	3.29
Jul 26	4.46
Jul 26	4.7
Jul 26	4.46
Jul 26	4.7
Jun 26	4.46
Jun 26	4.7
Jun 26	4.7
Jun 26	4.7
May 26	4.7
May 26	4.93
May 26	4.93
May 26	4.46
May 26	4.46
Apr 26	4.7
Apr 26	4.7
Apr 26	5.17
Apr 26	4.93
Mar 26	2.63
Mar 26	2.63
Mar 26	2.89
Mar 26	2.76
Feb 26	3.02
Feb 26	2.89
Feb 26	2.89
Feb 26	2.76
Jan 26	2.76
Jan 26	3.02
Jan 26	3.29
Jan 26	3.29
Jan 26	3.29
Dec 25	3.55
Dec 25	3.42
Dec 25	2.5
Dec 25	2.89
Nov 25	2.89
Nov 25	2.76
Nov 25	2.89
Nov 25	3.02
Oct 25	3.15
Oct 25	3.42
Oct 25	4.86
Oct 25	4.86
Oct 25	4.34
Sep 25	1.44
Sep 25	1.54
Sep 25	1.54
Sep 25	1.39
Aug 25	1.39
Aug 25	1.34
Aug 25	1.29
Aug 25	1.19
Aug 25	1.14
Jul 25	1.14
Jul 25	1.09
Jul 25	1.09
Jul 25	1.14
Jun 25	1.09
Jun 25	1.19
Jun 25	1.29
Jun 25	1.24
May 25	1.19
May 25	1.04
May 25	1.09
May 25	1.04
May 25	1.14
Apr 25	1.04
Apr 25	1.09
Apr 25	1.14
Apr 25	1.14
Mar 25	1.75
Mar 25	1.81
Mar 25	1.81
Mar 25	1.94
Feb 25	1.68
Feb 25	1.56
Feb 25	1.62
Feb 25	1.62
Jan 25	1.62
Jan 25	1.75
Jan 25	1.81
Jan 25	2.27
Jan 25	1.62
Dec 24	1.49
Dec 24	1.56
Dec 24	1.88
Dec 24	2.01
Nov 24	1.81
Nov 24	1.62
Nov 24	1.62
Nov 24	1.56
Nov 24	1.56
Oct 24	1.68

Price to Book

RAD.AX Price to Book by year
Period	Price to Book
Sep 26	0.57
Sep 26	0.57
Sep 26	0.64
Aug 26	0.64
Aug 26	0.71
Aug 26	0.78
Aug 26	0.85
Jul 26	0.99
Jul 26	1.35
Jul 26	1.42
Jul 26	1.35
Jul 26	1.42
Jun 26	1.35
Jun 26	1.42
Jun 26	1.42
Jun 26	1.42
May 26	1.42
May 26	1.49
May 26	1.49
May 26	1.35
May 26	1.35
Apr 26	1.42
Apr 26	1.42
Apr 26	1.56
Apr 26	1.49
Mar 26	1.09
Mar 26	1.09
Mar 26	1.2
Mar 26	1.14
Feb 26	1.25
Feb 26	1.2
Feb 26	1.2
Feb 26	1.14
Jan 26	1.14
Jan 26	1.25
Jan 26	1.36
Jan 26	1.36
Jan 26	1.36
Dec 25	1.47
Dec 25	1.42
Dec 25	1.03
Dec 25	1.2
Nov 25	1.2
Nov 25	1.14
Nov 25	1.2
Nov 25	1.25
Oct 25	1.31
Oct 25	1.42
Oct 25	2.02
Oct 25	2.02
Oct 25	1.8
Sep 25	0.22
Sep 25	0.23
Sep 25	0.23
Sep 25	0.21
Aug 25	0.21
Aug 25	0.2
Aug 25	0.19
Aug 25	0.18
Aug 25	0.17
Jul 25	0.17
Jul 25	0.16
Jul 25	0.16
Jul 25	0.17
Jun 25	0.16
Jun 25	0.18
Jun 25	0.19
Jun 25	0.19
May 25	0.18
May 25	0.16
May 25	0.16
May 25	0.16
May 25	0.17
Apr 25	0.16
Apr 25	0.16
Apr 25	0.17
Apr 25	0.17
Mar 25	0.36
Mar 25	0.37
Mar 25	0.37
Mar 25	0.4
Feb 25	0.35
Feb 25	0.32
Feb 25	0.33
Feb 25	0.33
Jan 25	0.33
Jan 25	0.36
Jan 25	0.37
Jan 25	0.47
Jan 25	0.33
Dec 24	0.31
Dec 24	0.32
Dec 24	0.39
Dec 24	0.41
Nov 24	0.37
Nov 24	0.33
Nov 24	0.33
Nov 24	0.32
Nov 24	0.32
Oct 24	0.35

No video analysis for this stock yet. Request one from our team.

News: RAD.AX

globenewswire.com · 17 Aug 2026

Radiopharm Theranostics To Meet with U.S. FDA to Align on Pivotal Phase 3 Trial Design for RAD 101 in Diagnosis of Brain Metastases

RAD 101 Phase 2b trial demonstrated 93% concordance with MRI across all evaluable lesions, meeting the Phase 2 trial's primary endpoint End-of-Phase 2 meeting with the U. S. FDA scheduled for October 1st, 2026; on track to be Phase 3 ready by year-end 2026 SYDNEY and MALVERN, Pa.

AI Analysis

Radiopharm Theranostics Limited

Video analysis: RAD.AX

News: RAD.AX

Radiopharm Theranostics To Meet with U.S. FDA to Align on Pivotal Phase 3 Trial Design for RAD 101 in Diagnosis of Brain Metastases

Similar companies